Fig. 4From: OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway(A–C) Drug sensitivity analysis results of OLFM2 high and low expression groups. (D–F) Immunotherapy analysis results of OLFM2 high and low expression groupsBack to article page